Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.
Fintel reports that on February 14, 2025, Piper Sandler downgraded their outlook for KORU Medical Systems (NasdaqCM:KRMD) ...